Business profile

Avansor Pharma Oy

Avansor Pharma Oy's registered office is Esbo. It is a limited company. The company was established on 2003-06-19. It operates in the industry of wholesale of pharmaceutical goods. In its latest retained statement for 2025-12-31, revenue was €3,267,178 and operating profit was €17,862.

Claim profileContact details
Business ID 1835834-2ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
1835834-2
Sector
Wholesale of pharmaceutical goods
Municipality
Esbo
Company form
Limited company
Registration date
2003-06-19
Business ID registration date
2003-06-06
Business status
Valid
Profile ownership
Unclaimed company profile
Data source
Public registry data

Contact and location summary

Visiting address: Tekniikantie 14, 02150, Esbo

Phone: +358504666881Source observation

Email: [email protected]Source observation

Website: https://www.avansorpharma.fiSource: registry data

Linkedin profile: https://www.linkedin.com/company/avansor-pharma-oySource: company website

People and decision-makers

Lindroos Carl-Johan ErikToimitusjohtaja

About Avansor Pharma Oy

Financial position and key figures for the company.

Avansor Pharma Oy's location municipality is Esbo. It is a limited company. The company was established on 2003-06-19. It operates in the industry of wholesale of pharmaceutical goods. In its latest retained statement for 2025-12-31, revenue was €3,267,178 and operating profit was €17,862. The latest retained financial statement for 2025-12-31 shows revenue of €3,267,178 and profit for the financial year of -€95,626. Based on the latest retained statement, revenue growth was -17.0%, operating margin was +0.6%, and equity ratio was +78.8%.

Financial highlights

Key figures from the latest financial period.

Latest financial period

2025-12-31

Imported periods0
PRH parsed0
Profile sourceEnriched source observation
Derived indicators
Revenue growth-17.0%
Operating margin0.6%
Equity ratio78.8%
Balance-sheet contextLatest retained period snapshot
Profit before taxes€52,296Previous: €1,560,170
Employees2Previous: 2
Revenue trend4 periods
€2,752,880
2022-12-31
€2,973,768
2023-12-31
€3,938,470
2024-12-31
€3,267,178
2025-12-31
Operating profit (loss) trend4 periods
€194,634
2022-12-31
€253,371
2023-12-31
€1,544,049
2024-12-31
€17,862
2025-12-31
Profit (loss) for the financial year trend4 periods
€149,251
2022-12-31
€174,129
2023-12-31
€1,094,319
2024-12-31
-€95,626
2025-12-31
Assets trend4 periods
€4,506,185
2022-12-31
€5,080,013
2023-12-31
€6,676,668
2024-12-31
€6,199,314
2025-12-31

Financial ratios

Financial ratios based on financial statement data. Source: Rikastettu lähdehavainto.

Equity ratioGood
98/100 · Improving
78.8 %2024-12-31: 76.8 %
Current ratioNot assessable
0/100 · Trend unavailable
Not available2024-12-31: Ei saatavilla
Operating profit marginPassable
51/100 · Declining
0.6 %2024-12-31: 38.4 %
Ratio history
Ratio2022-12-312023-12-312024-12-312025-12-31
Equity ratio91.2 %82.3 %76.8 %78.8 %
Current ratio----
Operating profit margin7.0 %8.5 %38.4 %0.6 %

Registry status and identifiers

Verified registry memberships and identifiers from the latest retained YTJ snapshot.

YTJ statusValid
Trade RegisterRegistered
Business ID1835834-2
VAT IDFI18358342
EU IDFIFPRO.1835834-2
MunicipalityEsbo
Current registered entries
2003-06-06Registered in Tax Administration (Prepayment Register)
2003-06-17Registered in Tax Administration (Tax Administration)
2003-06-19Registered in Patent and Registration Office (Trade Register)
2003-08-01VAT-liable for business activity in Tax Administration (VAT Register)
2006-03-01Registered in Tax Administration (Employer Register)

Responsible people

Public role relationships materialized from source observations.

Lindroos Carl-Johan ErikToimitusjohtajaSources: 4 · Confidence: 78%
Lindroos Hans GunnarPuheenjohtajaSources: 4 · Confidence: 78%
Lindroos Eva MariaProkuristiSources: 1 · Confidence: 78%
Lindroos Carl-Johan ErikVarsinainen jäsenSources: 1 · Confidence: 72%
Eva LindroosHallitus: varajäsenSources: 1 · Confidence: 76%
Juha HeikkolaPäävastuullinen tilintarkastajaSources: 1 · Confidence: 76%

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Financial data includedNot a credit decision
B1
StableAvansor Pharma Oy
Updated2026-08-24
ConfidenceMedium
Score69/100

The grade can use open digital financial statement data together with registry signals.

Risk context

When open digital financial statements are unavailable, BUSINESS.fi shows registry, industry, and regional context.

Industry riskelevated
45/100

Industry context is elevated based on normalized open statistical inputs.

Age and continuityVakiintunut
80/100

The company has about 23 years of registry continuity.

Registry and status signalsVakaa
88/100

Registry history, filing recency, and active register markings are still limited or mixed.

Registry timeline

Trade register notifications shown on a timeline.

31 register eventsLatest event: 2025-08-16

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

Avansor Pharma Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.